Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Testosterone: Functions and Regulation01:26

Testosterone: Functions and Regulation

2.4K
The intricate hormonal interplay essential for male reproductive health begins with the release of gonadotropin-releasing hormone (GnRH) by the hypothalamus. This hormone prompts the pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). LH targets the Leydig cells in the testes, stimulating them to produce and release testosterone. In concert with testosterone, FSH acts on the Sertoli cells within the seminiferous tubules to facilitate the release of...
2.4K
Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

5.2K
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
5.2K
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence01:22

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

216
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
216
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

1.3K
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
1.3K
Birth Control Methods01:22

Birth Control Methods

6.9K
Vasectomy is a surgical form of male sterilization that involves severing and sealing the vasa deferentia, preventing sperm from mixing with semen during ejaculation. Because a vasectomy does not impact the testes' ability to produce testosterone, hormone levels, libido, and sexual function generally remain unchanged. While vasectomy is highly effective in preventing pregnancy, with a success rate near 99.85%, rare cases of recanalization (spontaneous reconnection) can occur. Although...
6.9K
Drug Therapy01:28

Drug Therapy

315
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
315

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of androgen receptor polymorphism on hypogonadism severity and efficacy of testosterone replacement therapy.

Translational andrology and urology·2026
Same author

Impact of testosterone therapy and hypogonadism on treatment outcomes in Peyronie's disease: a multicenter retrospective analysis of collagenase clostridium histolyticum therapy.

The journal of sexual medicine·2026
Same author

Clinical outcomes in Peyronie's disease: impact of curvature severity and disease phase on symptom resolution and treatment response.

The journal of sexual medicine·2026
Same author

Sexual Health.

The Journal of urology·2026
Same author

Impact of HCV infection on male reproductive hormones; a systematic review and meta-analysis.

International journal of impotence research·2026
Same author

Early oncologic and functional outcomes of partial gland high-intensity focused ultrasound (HIFU) for prostate cancer: First 110 cases at a large U.S. tertiary referral center.

Urologic oncology·2026

Related Experiment Video

Updated: Feb 18, 2026

Combining Behavioral Endocrinology and Experimental Economics: Testosterone and Social Decision Making
11:51

Combining Behavioral Endocrinology and Experimental Economics: Testosterone and Social Decision Making

Published on: March 2, 2011

15.7K

Alternatives to Testosterone Therapy: A Review.

Eric M Lo1, Katherine M Rodriguez1, Alexander W Pastuszak2

  • 1Baylor College of Medicine, Houston, TX, USA.

Sexual Medicine Reviews
|November 28, 2017
PubMed
Summary

Concerns about testosterone therapy (TTh) safety and fertility preservation necessitate exploring alternatives. Non-testosterone treatments, including medical and lifestyle interventions, can effectively raise testosterone levels and should be considered before TTh.

Keywords:
Aromatase InhibitorsHuman Chorionic GonadotropinSelective Estrogen Receptor ModulatorTestosteroneTestosterone TherapyVaricocele

More Related Videos

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies
06:24

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies

Published on: January 10, 2025

1.6K
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.9K

Related Experiment Videos

Last Updated: Feb 18, 2026

Combining Behavioral Endocrinology and Experimental Economics: Testosterone and Social Decision Making
11:51

Combining Behavioral Endocrinology and Experimental Economics: Testosterone and Social Decision Making

Published on: March 2, 2011

15.7K
Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies
06:24

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies

Published on: January 10, 2025

1.6K
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.9K

Area of Science:

  • Endocrinology
  • Men's Health
  • Reproductive Medicine

Background:

  • Testosterone therapy (TTh) is a common treatment for hypogonadism.
  • Concerns exist regarding TTh's cardiovascular safety and impact on fertility.
  • The US FDA issued a warning about potential cardiovascular risks associated with TTh.

Purpose of the Study:

  • To review non-testosterone treatments for hypogonadism.
  • To evaluate medical and non-medical alternatives to conventional TTh.
  • To assess the role and limitations of these alternative therapies.

Main Methods:

  • Conducted a literature search using PubMed.
  • Included search terms related to hypogonadism and testosterone replacement alternatives.
  • Focused on peer-reviewed literature examining various treatment options.

Main Results:

  • Examined medical therapies: human chorionic gonadotropins, aromatase inhibitors, and selective estrogen receptor modulators.
  • Reviewed non-drug therapies: lifestyle modifications (diet, exercise, sleep, stress reduction), and varicocele repair.
  • Highlighted disease modification (e.g., addressing obesity, metabolic syndrome) as a potential treatment approach.

Conclusions:

  • Alternative therapies can increase testosterone levels.
  • These alternatives should be considered prior to initiating testosterone therapy.
  • Non-testosterone treatments offer viable options for managing hypogonadism.